Modulation of stress genes expression profile by nitric oxide-releasing aspirin in Jurkat T leukemia cells

Biochemical Pharmacology

Volumn 79, Issue 12, 2010, Pages 1759-1771

  Nath, Niharika ^a,b   Chattopadhyay, Mitali ^b   Kodela, Ravinder ^b   Tian, Song ^c   Vlismas, Peter ^a   Boring, Daniel ^d   Crowell, James A ^d   Kashfi, Khosrow ^b  

^a NEW YORK INSTITUTE OF TECHNOLOGY   (United States)

^b CITY UNIVERSITY OF NEW YORK MEDICAL SCHOOL   (United States)

^c SABiosciences ^*  (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Catenin; Anticancer; COX 2; Heat shock protein 70; NO releasing aspirin; Stress

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE 9; DIMETHYLANILINE MONOOXYGENASE; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN A1A; HEAT SHOCK PROTEIN A6; HEAT SHOCK PROTEIN H1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE DONATING ACETYLSALICYLIC ACID; PROTEIN FOS; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

ANTINEOPLASTIC AGENTS; ASPIRIN; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HSP70 HEAT-SHOCK PROTEINS; HUMANS; JURKAT CELLS; LEUKEMIA, T-CELL; MOLECULAR STRUCTURE; NEOPLASM PROTEINS; RNA INTERFERENCE;

EID: 77951294696     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2010.02.011     Document Type: Article

References (58)

1. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Thun M.J. Cancer statistics, 2009. CA Cancer J Clin 2009, 59:225-249.
2. Mikesch J.H., Steffen B., Berdel W.E., Serve H., Muller-Tidow C. The emerging role of Wnt signaling in the pathogenesis of acute myeloid leukemia. Leukemia 2007, 21:1638-1647.
3. Chung E.J., Hwang S.G., Nguyen P., Lee S., Kim J.S., Kim J.W., et al. Regulation of leukemic cell adhesion, proliferation, and survival by beta-catenin. Blood 2002, 100:982-990.
4. Lu D., Zhao Y., Tawatao R., Cottam H.B., Sen M., Leoni L.M., et al. Activation of the Wnt signaling pathway in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2004, 101:3118-3123.
5. Khan N.I., Bradstock K.F., Bendall L.J. Activation of Wnt/beta-catenin pathway mediates growth and survival in B-cell progenitor acute lymphoblastic leukaemia. Br J Haematol 2007, 138:338-348.
6. Cowin P., Rowlands T.M., Hatsell S.J. Cadherins and catenins in breast cancer. Curr Opin Cell Biol 2005, 17:499-508.
7. Nelson W.J., Nusse R. Convergence of Wnt, beta-catenin, and cadherin pathways. Science 2004, 303:1483-1487.
8. del Soldato P., Sorrentino R., Pinto A. NO-aspirins: a class of new anti-inflammatory and antithrombotic agents. Trends Pharmacol Sci 1999, 20:319-323.
9. Wallace J.L., Del Soldato P. The therapeutic potential of NO-NSAIDs. Fundam Clin Pharmacol 2003, 17:11-20.
10. Kashfi K., Ryan Y., Qiao L.L., Williams J.L., Chen J., Del Soldato P., et al. Nitric oxide-donating nonsteroidal anti-inflammatory drugs inhibit the growth of various cultured human cancer cells: evidence of a tissue type-independent effect. J Pharmacol Exp Ther 2002, 303:1273-1282.
11. Nath N., Vassell R., Chattopadhyay M., Kogan M., Kashfi K. Nitro-aspirin inhibits MCF-7 breast cancer cell growth: Effects on COX-2 expression and Wnt/beta-catenin/TCF-4 signaling. Biochem Pharmacol 2009, 15:1298-1304.
12. Bak A.W., McKnight W., Li P., Del Soldato P., Calignano A., Cirino G., et al. Cyclooxygenase-independent chemoprevention with an aspirin derivative in a rat model of colonic adenocarcinoma. Life Sci 1998, 62:367-373.
13. Ouyang N., Williams J.L., Tsioulias G.J., Gao J., Iatropoulos M.J., Kopelovich L., et al. Nitric oxide-donating aspirin prevents pancreatic cancer in a hamster tumor model. Cancer Res 2006, 66:4503-4511.
14. Williams J.L., Kashfi K., Ouyang N., del Soldato P., Kopelovich L., Rigas B. NO-donating aspirin inhibits intestinal carcinogenesis in Min (APC(Min/+)) mice. Biochem Biophys Res Commun 2004, 313:784-788.
15. Nath N., Kashfi K., Chen J., Rigas B. Nitric oxide-donating aspirin inhibits beta-catenin/T cell factor (TCF) signaling in SW480 colon cancer cells by disrupting the nuclear beta-catenin-TCF association. Proc Natl Acad Sci USA 2003, 100:12584-12589.
16. Gao J., Liu X., Rigas B. Nitric oxide-donating aspirin induces apoptosis in human colon cancer cells through induction of oxidative stress. Proc Natl Acad Sci USA 2005, 102:17207-17212.
17. Nath N., Labaze G., Rigas B., Kashfi K. NO-donating aspirin inhibits the growth of leukemic Jurkat cells and modulates beta-catenin expression. Biochem Biophys Res Commun 2005, 326:93-99.
18. Kashfi K. Anti-inflammatory agents as cancer therapeutics. Adv Pharmacol 2009, 57:31-89.
19. Bronte V., Serafini P., Mazzoni A., Segal D.M., Zanovello P. l-Arginine metabolism in myeloid cells controls T-lymphocyte functions. Trends Immunol 2003, 24:302-306.
20. Penning T.D., Talley J.J., Bertenshaw S.R., Carter J.S., Collins P.W., Docter S., et al. Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib). J Med Chem 1997, 40:1347-1365.
21. Wilkerson D.C., Skaggs H.S., Sarge K.D. HSF2 binds to the Hsp90, Hsp27, and c-Fos promoters constitutively and modulates their expression. Cell Stress Chaperones 2007, 12:283-290.
22. Schiaffonati L., Tiberio L. Gene expression in liver after toxic injury: analysis of heat shock response and oxidative stress-inducible genes. Liver 1997, 17:183-191.
23. Akerfelt M., Trouillet D., Mezger V., Sistonen L. Heat shock factors at a crossroad between stress and development. Ann N Y Acad Sci 2007, 1113:15-27.
24. Parcellier A., Gurbuxani S., Schmitt E., Solary E., Garrido C. Heat shock proteins, cellular chaperones that modulate mitochondrial cell death pathways. Biochem Biophys Res Commun 2003, 304:505-512.
25. Noonan E.J., Place R.F., Giardina C., Hightower L.E. Hsp70B' regulation and function. Cell Stress Chaperones 2007, 12:219-229.
26. Leppa S., Kajanne R., Arminen L., Sistonen L. Differential induction of Hsp70-encoding genes in human hematopoietic cells. J Biol Chem 2001, 276:31713-31719.
27. Jolly C., Morimoto R.I. Role of the heat shock response and molecular chaperones in oncogenesis and cell death. J Natl Cancer Inst 2000, 92:1564-1572.
28. Garrido C., Gurbuxani S., Ravagnan L., Kroemer G. Heat shock proteins: endogenous modulators of apoptotic cell death. Biochem Biophys Res Commun 2001, 286:433-442.
29. Koren J., Jinwal U.K., Jin Y., O'Leary J., Jones J.R., Johnson A.G., et al. Facilitating Akt clearance via manipulation of Hsp70 activity and levels. J Biol Chem 2010, 285:2498-2505.
30. Jurivich D.A., Sistonen L., Kroes R.A., Morimoto R.I. Effect of sodium salicylate on the human heat shock response. Science 1992, 255:1243-1245.
31. Batulan Z., Nalbantoglu J., Durham H.D. Nonsteroidal anti-inflammatory drugs differentially affect the heat shock response in cultured spinal cord cells. Cell Stress Chaperones 2005, 10:185-196.
32. Song J., Takeda M., Morimoto R.I. Bag1-Hsp70 mediates a physiological stress signalling pathway that regulates Raf-1/ERK and cell growth. Nat Cell Biol 2001, 3:276-282.
33. Teiten M.H., Reuter S., Schmucker S., Dicato M., Diederich M. Induction of heat shock response by curcumin in human leukemia cells. Cancer Lett 2009, 279:145-154.
34. Multhoff G., Botzler C., Jennen L., Schmidt J., Ellwart J., Issels R. Heat shock protein 72 on tumor cells: a recognition structure for natural killer cells. J Immunol 1997, 158:4341-4350.
35. Multhoff G. Activation of natural killer cells by heat shock protein 70. Int J Hyperthermia 2002, 18:576-585.
36. Gehrmann M., Radons J., Molls M., Multhoff G. The therapeutic implications of clinically applied modifiers of heat shock protein 70 (Hsp70) expression by tumor cells. Cell Stress Chaperones 2008, 13:1-10.
37. Massa C., Guiducci C., Arioli I., Parenza M., Colombo M.P., Melani C. Enhanced efficacy of tumor cell vaccines transfected with secretable hsp70. Cancer Res 2004, 64:1502-1508.
38. De Santo C., Serafini P., Marigo I., Dolcetti L., Bolla M., Del Soldato P., et al. Nitroaspirin corrects immune dysfunction in tumor-bearing hosts and promotes tumor eradication by cancer vaccination. Proc Natl Acad Sci USA 2005, 102:4185-4190.
39. Williams J.L., Nath N., Chen J., Hundley T.R., Gao J., Kopelovich L., et al. Growth inhibition of human colon cancer cells by nitric oxide (NO)-donating aspirin is associated with cyclooxygenase-2 induction and beta-catenin/T-cell factor signaling, nuclear factor-kappaB, and NO synthase 2 inhibition: implications for chemoprevention. Cancer Res 2003, 63:7613-7618.
40. Prestes-Carneiro L.E., Shio M.T., Fernandes P.D., Jancar S. Cross-regulation of iNOS and COX-2 by its products in murine macrophages under stress conditions. Cell Physiol Biochem 2007, 20:283-292.
41. Zhang F., Hackett N.R., Lam G., Cheng J., Pergolizzi R., Luo L., et al. Green fluorescent protein selectively induces HSP70-mediated up-regulation of COX-2 expression in endothelial cells. Blood 2003, 102:2115-2121.
42. Kiang J.G., Kiang S.C., Juang Y.T., Tsokos G.C. N(omega)-nitro-L-arginine inhibits inducible HSP-70 via Ca(2+), PKC, and PKA in human intestinal epithelial T84 cells. Am J Physiol Gastrointest Liver Physiol 2002, 282:G415-G423.
43. Thomas S.C., Ryan M.A., Shanley T.P., Wong H.R. Induction of the stress response with prostaglandin A1 increases I-kappaBalpha gene expression. FASEB J 1998, 12:1371-1378.
44. Knowlton A.A. NFkappaB, heat shock proteins, HSF-1, and inflammation. Cardiovasc Res 2006, 69:7-8.
45. Board P.G., Coggan M., Chelvanayagam G., Easteal S., Jermiin L.S., Schulte G.K., et al. Identification, characterization, and crystal structure of the Omega class glutathione transferases. J Biol Chem 2000, 275:24798-24806.
46. MacDonald C.J., Cheng R.Y., Roberts D.D., Wink D.A., Yeh G.C. Modulation of carcinogen metabolism by nitric oxide-aspirin 2 is associated with suppression of DNA damage and DNA adduct formation. J Biol Chem 2009, 284:22099-22107.
47. Gao J., Kashfi K., Liu X., Rigas B. NO-donating aspirin induces phase II enzymes in vitro and in vivo. Carcinogenesis 2006, 27:803-810.
48. Nioi P., Hayes J.D. Contribution of NAD(P)H:quinone oxidoreductase 1 to protection against carcinogenesis, and regulation of its gene by the Nrf2 basic-region leucine zipper and the arylhydrocarbon receptor basic helix-loop-helix transcription factors. Mutat Res 2004, 555:149-171.
49. Neumann C.A., Fang Q. Are peroxiredoxins tumor suppressors?. Curr Opin Pharmacol 2007, 7:375-380.
50. Krueger S.K., Williams D.E. Mammalian flavin-containing monooxygenases: structure/function, genetic polymorphisms and role in drug metabolism. Pharmacol Ther 2005, 106:357-387.
51. Ress A., Moelling K. Bcr is a negative regulator of the Wnt signalling pathway. EMBO Rep 2005, 6:1095-1100.
52. Arlinghaus R.B. Bcr: a negative regulator of the Bcr-Abl oncoprotein in leukemia. Oncogene 2002, 21:8560-8567.
53. Scott D.W., Loo G. Curcumin-induced GADD153 gene up-regulation in human colon cancer cells. Carcinogenesis 2004, 25:2155-2164.
54. Gotoh T., Oyadomari S., Mori K., Mori M. Nitric oxide-induced apoptosis in RAW 264.7 macrophages is mediated by endoplasmic reticulum stress pathway involving ATF6 and CHOP. J Biol Chem 2002, 277:12343-12350.
55. Zhou S., Schuetz J.D., Bunting K.D., Colapietro A.M., Sampath J., Morris J.J., et al. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med 2001, 7:1028-1034.
56. Grommes C., Landreth G.E., Heneka M.T. Antineoplastic effects of peroxisome proliferator-activated receptor gamma agonists. Lancet Oncol 2004, 5:419-429.
57. Gertsch J., Guttinger M., Heilmann J., Sticher O. Curcumin differentially modulates mRNA profiles in Jurkat T and human peripheral blood mononuclear cells. Bioorg Med Chem 2003, 11:1057-1063.
58. Reuter S., Eifes S., Dicato M., Aggarwal B.B., Diederich M. Modulation of anti-apoptotic and survival pathways by curcumin as a strategy to induce apoptosis in cancer cells. Biochem Pharmacol 2008, 76:1340-1351.